OTC •
Healthcare •
Biotechnology •
Quote as of 05/22/2026 15:53
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.8614 mln
Float133 mln
Earnings Date05/15/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-1.61
Likely manipulated
Relative Strength
93
/ 100
Top performer
Debt / Equity
-0.73
Negative equity
Pre-Tax Margin
7%
Low margin
Dividend Yield
0.00%
No dividend
Business Description
Evofem Biosciences is a San Diego-based company focused exclusively on women's health, offering two distinct prescription products. PHEXXI provides a non-hormonal birth control option in gel form, while SOLOSEC treats common vaginal infections with a single oral dose.
